Sponsored Research
Svati Shah of Cardiology has received a sub-award () through the Columbia University for a project entitled "Columbia - Impetus: Finding Aging biomarkers by Searching existing Trials (FAST) Initiative." Total funding will be $104,333.
Chenyu Lin of Cell Therapy has received a sub-award (3U01-FD007857-02S7) through the University of North Carolina - Chapel Hill for a project entitled "Racial and Ethnic Differences in the Real-World Clinical Outcomes of IDH1 and IDH2 Inhibitors in Acute Myeloid Leukemia." Total funding will be $73,590.
Joshua Thaden of Infectious Diseases has received a sub-award (5-UM1AI104681-12) through the DCRI-Duke-Site for a project entitled "OPTIMIZE." Total funding will be $1.
Carey Anders of Oncology has received a sub-award () through the Johns Hopkins University for a project entitled "Aurora US: Prospective Biospecimen Repository in Metastatic Breast Cancer." Total funding will be $28,988.
Andrew Nixon of Oncology has received a sub-award () through the University of Chicago for a project entitled "Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH)." Total funding will be $85,689.
Aparna Swaminathan of Pulmonary has received a sub-award () through the Ann & Robert H. Lurie Children's Hospital of Chicago for a project entitled "Comparative effectiveness of VNS versus continued pharmacologic treatment of Lennox-Gastaut Syndrome." Total funding will be $1.
Jamie Todd of Pulmonary has received an award from the Cystic Fibrosis Foundation for a project entitled "Incorporating early posttransplant club cell secretory protein measures into individual risk prediction models for long term lung allograft function outcomes." Total funding will be $112,000.
An-Kwok Wong of Pulmonary has received an award (1R01-HL177003-01) from the National Institutes of Health for a project entitled "Overcoming inequities in Pulse oximetry Through clinical InformatiCs (OPTIC)." Total funding will be $3,400,930.
Industry Sponsored Clinical Trials
Richa Agarwal of Cardiology has received an award from Abbott Laboratories for a project entitled "Advanced Heart Failure and transplant cardiology fellowship grant." Total funding will be $40,000.
Gary Felker of Cardiology has received an award from Bayer Aktiengesellschaft (same as Bayer AG) for a project entitled "Bayer Alliance Management Funding." Total funding will be $788,220.
Christopher Granger of Cardiology has received an award from Novo Nordisk, Inc. for a project entitled "Implementation Summit- think tank- LOI." Total funding will be $25,000.
Christopher Granger of Cardiology has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "Implementation Summit- think tank- Boehringer Ingelheim." Total funding will be $25,000.
Donald Hegland of Cardiology has received an award from Abbott Laboratories for a project entitled "Duke Clinical Cardiac Electrophysiology Fellowship Program Grant." Total funding will be $30,000.
Ravi Karra of Cardiology has received an award from Salubris Biotherapeutics, Inc. (SalubrisBio) for a project entitled "A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure." Total funding will be $437,564.
Jonathan Piccini of Cardiology has received an award from St. Jude Medical Business Services Inc. for a project entitled "CRD 1074 FlexPulse - Safety and effectiveness of the TactiFlex SE Catheter and Volt Pulsed Field Ablation (PFA) Generator in subjects with paroxysmal atrial fibrillation." Total funding will be $64,085.
Sudarshan Rajagopal of Cardiology has received an award from United Therapeutics Corporation for a project entitled "GMS-PH-401 Pro00116519." Total funding will be $83,102.
Lindsay Rein of Cell Therapy has received an award from Kartos Therapeutics, Inc. for a project entitled "A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib." Total funding will be $1,321,173.
Jonathan Campbell of Endocrinology has received an award from Eli Lilly and Company for a project entitled "Development of a multiplex, metabolic flux approach to quantify nutrient metabolism." Total funding will be $700,001.
Vance Fowler of Infectious Diseases has received an award from MedImmune Limited for a project entitled "Klebsiella Isolate Study." Total funding will be $433,244.
Goni Katz-Greenberg of Nephrology has received an award from Argenx BVBA for a project entitled "Efgartigimod in Kidney Transplant Recipients With AMR - SHAMROCK Pro00116061." Total funding will be $339,357.
Rani Bansal of Oncology has received an award from Jazz Pharmaceuticals for a project entitled "A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician's choice chemo, for the treatment of participants with metastatic HER2-positive breast cancer." Total funding will be $455,984.
Rani Bansal of Oncology has received an award from Eisai, Inc. for a project entitled "An Open-label, Multicenter, Phase 2 Dose Optimization and Expansion Study to Evaluate the Safety and Efficacy of BB-1701, an anti-human epidermal growth factor receptor 2 (anti-HER2) antibody-drug conjugate (ADC), in Previously Treated Subjects with." Total funding will be $29,118.
Niharika Mettu of Oncology has received an award from Amgen, Inc. for a project entitled "A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion Master." Total funding will be $1,365,797.
Eziafa Oduah of Oncology has received an award from OncoC4 for a project entitled "Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors." Total funding will be $646,701.
Richard Riedel of Oncology has received an award from SynOx Therapeutics Ltd for a project entitled "A Phase II, Multi-centre, Randomised, Double-blind, Group Comparator Trial to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Patients with Tenosynovial Giant Cell Tumour,." Total funding will be $279,267.
Yuh Chin Huang of Pulmonary has received an award from Chiesi Farmaceutici S.p.A. for a project entitled "PILLAR CLI-06001AA1-05 Chiesi." Total funding will be $804,085.
Teresa Tarrant of Rheumatology has received an award from X4 Pharmaceuticals for a project entitled "A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of mavorixafor in participants with congenital and acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infec." Total funding will be $168,952.